Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery
Status:
Terminated
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
Pre-treatment of patients with erythropoietin subcutaneously and iron supplement
intravenously, in order to create a clinical pathway to minimize transfusion of red blood
cells in a selected group of cardiac patients with an increased risk for blood transfusions
in our cardiac surgery program.